HealthFlex
×
  • About Us
    • Management
    • Family of Companies
    • History
    • Facilities
    • Humane Care Commitment
    •  Board of Directors
  • Services
    • Toxicology
    • Bioanalytical / Analytical Chemistry
    • Pharmacokinetics / Toxicokinetics
    • Formulation
    • Pharmacology
    • Agrochemicals and Commodity Chemicals
    • Colony Maintenance
    • Ocular
  • Specialty Expertise
    • Respiratory
    • Infectious Disease
    • Gene Therapy
    • Neuroscience
    • Alternative Tobacco Products
    • Medical Countermeasures
  • COVID-19 Research
  • News
    • Publications
    • Blog
  • Careers
    • Benefits & Compensation
  • Contact
  • For Employees
Lovelace Biomedical Operations During the Coronavirus Pandemic

Lovelace Biomedical Welcomes New Scientific Advisor and Infectious Disease Program Contributor

August 18, 2020news

Chad J. Roy, Ph.D

Lovelace Biomedical Welcomes New Scientific Advisor and Infectious Disease Program Fellow Chad J. Roy

Lovelace Biomedical is proud to announce and welcome the addition of Tulane Professor Dr. Chad J. Roy as Lovelace Fellow. In that capacity, Dr. Roy will work our scientific team to expand existing collaborations to capitalize and expand capabilities in infectious disease. For over 20 years Dr. Roy has been a pioneer in the area of aerobiology and animal modeling to help support infectious disease animal model development.

“This is a natural evolution of the collaborations and scientific interaction I have been developing with Lovelace over the past ten years”, indicates Dr. Roy.

As a Lovelace Fellow, he will have a scientific appointment, will participate in strategic initiatives and pilot research programs, and will serve as co-investigator on programs.

“We are proud to formalize our relationship with Chad. He has established himself in infectious disease research, and his vision of how we can collaborate and he can help build our program is aligned with our goals for the Institute. We are proud to formalize our ongoing collaboration”, Dr. Jake McDonald says, Site Director for Lovelace Biomedical.

See more about our infectious disease capabilities

Follow us to keep up with our latest news:

http://www.linkedin.com/company/lovelace-biomedical

www.twitter.com/lovelacebio

Recent News

  • Lovelace Biomedical to Present Webinar on Inhalation Toxicology for a Range of Drug Classes
  • Lovelace Biomedical Welcomes New Scientific Advisor and Infectious Disease Program Contributor
  • Published: Scientific paper from our Lung Cancer Program – The affects of e-liquid acquired from vaping
  • Webinar – Clinical and Translational Response to COVID-19
  • Lovelace Biomedical and National Jewish Health to Host Webinar; Clinical and Translational Response to COVID-19

For General needs and employment verification

(505) 348-9361

info@lrri.org

www.lovelacebiomedical.org

2425 Ridgecrest Dr. SE, Albuquerque, NM 87108-5127

For Business Development Needs

For Business Development Needs

(202) 819-5108

mmcmullen@lovelacebiomedical.org

www.lovelacebiomedical.org

2425 Ridgecrest Dr. SE, Albuquerque, NM 87108-5127

Quick Links

  • Home
  • About Us
  • History
  • Humane Care Commitment
  • Services
  • Specialty Expertise
  • News
  • Careers
  • Preclinical COVID-19 Research
  • Contact

Latest News

  • From Our Blog: PCR Development, it’s Uses, and Important Research at Lovelace Biomedical, with Bryan Gullick, PhD, Bioanalytical Research Scientist Jan 28

    Staff Spotlight: Bryan Gullick, PhD, Research Scientist Bryan, tell us about PCR in the development and conduct of...

  • Blog: Preclinical Drug Development for a Gene Therapy Product: No Cookie Cutter Route Jan 11

    Preclinical Drug Development for a Gene Therapy Product: No Cookie Cutter Route   Follow these critical steps...

Copyright © 2018 Lovelace Biomedical. All Rights Reserved.
Powered by J B Soft System, Chennai.